# Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/adoptive-immunotherapy-to-lower-postsurgical-recurrence-rates-of-hepatocellular/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tadatoshi Takayama,Teruaki Sekine,Masatoshi Makuuchi,Susumu Yamasaki,Tomoo Kosuge,Junji Yamamoto,Kazuaki Shimada,Michiie Sakamoto,Setsuo Hirohashi,Yasuo Ohashi,Tadao Kakizoe |
| Citations | 849 |
| DOI | 10.1016/s0140-6736(00)02654-4 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2099657378 |
| PMID | 11022927 |
| Type | article |
| Year | 2000 |

## Paper authors

- [Yasuo Ohashi](https://scholariq.org/researchers/yasuo-ohashi/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.